| 000 | 01661 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518010949.0 | ||
| 264 | 0 | _c20191203 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1880-3873 | ||
| 024 | 7 |
_a10.5551/jat.46151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Sheng-Feng | |
| 245 | 0 | 0 |
_aLow Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study. _h[electronic resource] |
| 260 |
_bJournal of atherosclerosis and thrombosis _cJun 2019 |
||
| 300 |
_a513-527 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Validation Study | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracranial Hemorrhages _xblood |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 700 | 1 | _aChao, A-Ching | |
| 700 | 1 | _aHu, Han-Hwa | |
| 700 | 1 | _aLin, Ruey-Tay | |
| 700 | 1 | _aChen, Chih-Hung | |
| 700 | 1 | _aChan, Lung | |
| 700 | 1 | _aLin, Huey-Juan | |
| 700 | 1 | _aSun, Yu | |
| 700 | 1 | _aLin, Yung-Yang | |
| 700 | 1 | _aChen, Po-Lin | |
| 700 | 1 | _aLin, Shinn-Kuang | |
| 700 | 1 | _aWei, Cheng-Yu | |
| 700 | 1 | _aLin, Yu-Te | |
| 700 | 1 | _aLee, Jiunn-Tay | |
| 700 | 1 | _aBai, Chyi-Huey | |
| 773 | 0 |
_tJournal of atherosclerosis and thrombosis _gvol. 26 _gno. 6 _gp. 513-527 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5551/jat.46151 _zAvailable from publisher's website |
| 999 |
_c29078675 _d29078675 |
||